Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec;11(4):616-623.
doi: 10.1007/s12178-018-9522-z.

Platelet-rich plasma in the foot and ankle

Peter R Henning  1 , Benjamin J Grear  2
Affiliations
Review

Platelet-rich plasma in the foot and ankle

Peter R Henning et al. Curr Rev Musculoskelet Med. 2018 Dec.

Abstract

Purpose of review: Platelet-rich plasma has become an increasingly popular treatment option within the orthopedic community to biologically enhance and stimulate difficult-to-heal musculoskeletal tissues. This review evaluates the recent literature on platelet-rich plasma use in the treatment of foot and ankle pathologies.

Recent findings: Recent literature has demonstrated platelet-rich plasma to have a possible benefit in the treatment of Achilles pathology, chronic plantar fasciitis, osteochondral lesions of the talus, ankle osteoarthritis, and diabetic foot ulcers. However, given the lack of standardization of platelet-rich plasma preparations and protocols and the predominance of low-quality studies, no definitive treatment indications exist. Platelet-rich plasma is a promising treatment option, but at present, there is only limited clinical evidence supporting its use in foot and ankle applications.

Keywords: Achilles; Foot and ankle; Orthobiologics; PRP; Platelet-rich plasma.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

Both authors declare no conflicts of interest.

Human and animal rights and informed consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

    1. Alves R, Grimalt R. A review of platelet-rich plasma: history, biology, mechanism of action, and classification. Skin Appendage Disord. 2018;4(1):18–24. doi: 10.1159/000477353. - DOI - PMC - PubMed
    1. Andia I., Rubio-Azpeitia E., Martin J.I., Abate M. Biotechnology. 2015. Current Concepts and Translational Uses of Platelet Rich Plasma Biotechnology.
    1. Hall MP, Band PA, Meislin RJ, Jazrawi LM, Cardone DA. Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg. 2009;17(10):602–608. doi: 10.5435/00124635-200910000-00002. - DOI - PubMed
    1. Administration FaD. Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products. Minimal manipulation and homologous use. In: Services USDoHaH, editor. Maryland: U.S. Department of Health and Human Services. p. 2017.
    1. Mishra A, Tummala P, King A, Lee B, Kraus M, Tse V, et al. Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Engineering Part C, Methods. 2009;15(3):431–435. doi: 10.1089/ten.tec.2008.0534. - DOI - PMC - PubMed